Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects) - Tapa blanda

 
9781441926081: Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects)

Sinopsis

A particular issue for biopharmaceuticals that has not been addressed comprehensively in any book, is the potential of an immune response to the biopharmaceutical product. That is, the human body marks the drug as a foreign body, and develops antibodies against the drug. These antibodies may be relatively harmless, but may also cross-react with the endogenous compound, causing autoimmunogenicity. Recent adverse experiences in Europe with Janssen-Ortho’s blockbuster product Eprex has increased the attention towards potential immunogenicity of biopharmaceuticals, above all from the regulatory agencies.

This book is intended to give a broad overview of the current state-of-the-art regarding the immune response to biopharmaceuticals. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity.

"Sinopsis" puede pertenecer a otra edición de este libro.

Reseña del editor

Immunogenicity of Biopharmaceuticals is the first book to comprehensively address the potential of an immune response to biopharmaceuticals. It is intended to give a broad overview of the current state-of-the-art regarding this subject. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity.

"Sobre este título" puede pertenecer a otra edición de este libro.

Otras ediciones populares con el mismo título

9780387758404: Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)

Edición Destacada

ISBN 10:  0387758402 ISBN 13:  9780387758404
Editorial: Springer, 2007
Tapa dura